The N- and C-terminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity

Molecular Immunology

Volumn 48, Issue 4, 2011, Pages 670-677

  Li, Yurong ^a   Feng, Jiannan ^a   Geng, Shaoxia ^a,c   Geng, Shusheng ^b   Wei, Huawei ^a   Chen, Guojiang ^a   Li, Xinying ^a   Wang, Liyan ^a   Wang, Renxi ^a   Peng, Hui ^a   Han, Gencheng ^a   Shen, Beifen ^a   Li, Yan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b Beijing Development Area   (China)

^c HENAN UNIVERSITY   (China)

Author keywords

Adaptive immunity; CRD; Galectin 9; Innate immunity

Indexed keywords

CARBOHYDRATE; ECALECTIN; HOMODIMER; HYBRID PROTEIN; I KAPPA B ALPHA; INTERLEUKIN 6; RECOMBINANT PROTEIN; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARBOHYDRATE RECOGNITION DOMAIN; CARBOXY TERMINAL SEQUENCE; CELL DEATH; COMPARATIVE STUDY; COMPUTER ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HYPOTHESIS; INNATE IMMUNITY; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; RECEPTOR BINDING; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADAPTIVE IMMUNITY; ANIMALS; CARBOHYDRATES; CD4-POSITIVE T-LYMPHOCYTES; CELL DEATH; CELL LINE; DENDRITIC CELLS; GALECTINS; HUMANS; IMMUNITY, INNATE; LYMPHOCYTE ACTIVATION; MICE; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, VIRUS; RECOMBINANT PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 78650602530     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.11.011     Document Type: Article

References (35)

1. Anderson A.C., Anderson D.E., Bregoli L., Hastings W.D., Kassam N., Lei C., Chandwaskar R., Karman J., Su E.W., Hirashima M., Bruce J.N., Kane L.P., Kuchroo V.K., Hafler D.A. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 2007, 318(5853):1141-1143.
2. Barondes S.H., Castronovo V., Cooper D.N.W., Cummings R.D., Drickamer K., Feizi T., et al. Galectins: a family of animal beta-galactoside-binding lectins. Cell 1994, 76:597-598.
3. Bi S., Earl L.A., Jacobs L., Baum L.G. Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways. J. Biol. Chem. 2008, 283(18):12248-12258.
4. Cao E., Zang X., Ramagopal U.A., Mukhopadhaya A., Fedorov A., Fedorov E., Zencheck W.D., Lary J.W., Cole J.L., Deng H., Xiao H., Dilorenzo T.P., Allison J.P., Nathenson S.G., Almo S.C. T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface. Immunity 2007, 26(3):311-321.
5. Chou F.C., Shieh S.J., Sytwu H.K. Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice. Eur. J. Immunol. 2009, 39(9):2403-2411.
6. Dai S.Y., Nakagawa R., Itoh A., Murakami H., Kashio Y., Abe H., Katoh S., Kontani K., Kihara M., Zhang S.L., Hata T., Nakamura T., Yamauchi A., Hirashima M. Galectin-9 induces maturation of human monocyte-derived dendritic cells. J. Immunol. 2005, 175(5):2974-2981.
7. Hastings W.D., Anderson D.E., Kassam N., Koguchi K., Greenfield E.A., Kent S.C., Zheng X.X., Strom T.B., Hafler D.A., Kuchroo V.K. TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur. J. Immunol. 2009, 39(9):2492-2501.
8. He W., Fang Z., Wang F., Wu K., Xu Y., Zhou H., Du D., Gao Y., Zhang W.N., Niki T., Hirashima M., Yuan J., Chen Z.K. Galectin-9 significantly prolongs the survival of fully mismatched cardiac allografts in mice. Transplantation 2009, 88(6):782-790.
9. Hirabayashi J., Hashidate T., Arata Y., Nishi N., Nakamura T., Hirashima M., et al. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim. Biophys. Acta 2002, 1572:232-254.
10. Hirabayashi J., Nagae M., Nishi N., Nakamura-Tsuruta S., Wakatsuki S., Kato R. Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue. J. Mol. Biol. 2008, 375:119-135.
11. Kashio Y., Nakamura K., Abedin M.J., et al. Galectin-9 induces apoptosis through the calcium-calpain caspase-1 pathway. J. Immunol. 2003, 170:3631-3636.
12. Koguchi K., Anderson D.E., Yang L., O'Connor K.C., Kuchroo V.K., Hafler D.A. Dysregulated T cell expression of TIM3 in multiple sclerosis. J. Exp. Med. 2006, 203(6):1413-1418.
13. Kuchroo V.K., Dardalhon V., Xiao S., Anderson A.C. New roles for TIM family members in immune regulation. Nat. Rev. Immunol. 2008, 8(8):577-580.
14. Lu L.H., Nakagawa R., Kashio Y., Ito A., Shoji H., Nishi N., Hirashima M., Yamauchi A., Nakamura T. Characterization of galectin-9-induced death of Jurkat T cells. J. Biochem. 2007, 141(2):157-172.
15. Matsushita N., Nishi N., Seki M., Matsumoto R., Kuwabara I., Liu F.-T., et al. Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction. J. Biol. Chem. 2000, 275:8355-8360.
16. McDunn J.E., Muenzer J.T., Rachdi L., Chang K.C., Davis C.G., Dunne W.M., Piwnica-Worms D., Bernal-Mizrachi E., Hotchkiss R.S. Peptide-mediated activation of AKT and extracellular regulated kinase signalling prevents lymphocyte apoptosis. FASEB J. 2008, 22:561-568.
17. Mengshol J.A., Golden-Mason L., Arikawa T., Smith M., Niki T., McWilliams R., Randall J.A., McMahan R., Zimmerman M.A., Rangachari M., Dobrinskikh E., Busson P., Polyak S.J., Hirashima M., Rosen H.R. A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PLoS One 2010, 5(3):e9504.
18. Mitsuomi H., Yumiko K., Nozomu N., et al. Galectin-9 in physiological and pathological conditions. Glycoconj. J. 2004, 19:593-600.
19. Nagahara K., Arikawa T., Oomizu S., Kontani K., Nobumoto A., Tateno H., Watanabe K., Niki T., Katoh S., Miyake M., Nagahata S., Hirabayashi J., Kuchroo V.K., Yamauchi A., Hirashima M. Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions. J. Immunol. 2008, 181(11):7660-7669.
20. Nishi N., Itoh A., Fujiyama A., Yoshida N., Araya S., Hirashima M., Shoji H., Nakamura T. Development of highly stable galectins: truncation of the linker peptide confers protease-resistance on tandem-repeat type galectins. FEBS Lett. 2005, 579(10):2058-2064.
21. Niwa H., Satoh T., Matsushima Y., Hosoya K., Saeki K., Niki T., Hirashima M., Yokozeki H. Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1- and/or Th17-mediated skin inflammation. Clin. Immunol. 2009, 132(2):184-194.
22. Nobumoto A., Oomizu S., Arikawa T., Katoh S., Nagahara K., Miyake M., Nishi N., Takeshita K., Niki T., Yamauchi A., Hirashima M. Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice. Clin. Immunol. 2009, 130(3):322-330.
23. Sánchez-Fueyo A., Tian J., Picarella D., Domenig C., Zheng X.X., Sabatos C.A., Manlongat N., Bender O., Kamradt T., Kuchroo V.K., Gutiérrez-Ramos J.C., Coyle A.J., Strom T.B. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat. Immunol. 2003, 4(11):1093-1101.
24. Sato M., Nishi N., Shoji H., Seki M., Hashidate T., Hirabayashi J., et al. Functional analysis of the carbohydrate recognition domains and a linker peptide of galectin-9 as to eosinophil chemoattractant activity. Glycobiology 2002, 12:191-197.
25. Sehrawat S., Suryawanshi A., Hirashima M., Rouse B.T. Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. J. Immunol. 2009, 182(5):3191-3201.
26. Seki M., Oomizu S., Sakata K.M., Sakata A., Arikawa T., Watanabe K., Ito K., Takeshita K., Niki T., Saita N., Nishi N., Yamauchi A., Katoh S., Matsukawa A., Kuchroo V., Hirashima M. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin. Immunol. 2008, 127(1):78-88.
27. Sweeney E.A., Inokuchi J., Igarashi Y. Inhibition of sphingolipid induced apoptosis by caspase inhibitors indicates that sphingosine acts in an earlier part of the apoptotic pathway than ceramide. FEBS Lett. 1998, 425:61.
28. Sziksz E., Kozma G.T., Pállinger E., Komlósi Z.I., Adori C., Kovács L., Szebeni B., Rusai K., Losonczy G., Szabó A., Vannay A. Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice. Int. Arch. Allergy Immunol. 2010, 151(4):308-317.
29. Türeci O., Schmitt H., Fadle N., Pfreundschuh M., Sahin U. Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J. Biol. Chem. 1997, 272(10):6416-6422.
30. Vu C.C., Bortner C.D., Cidlowski J.A. Differential involvement of initiator caspases in apoptotic volume decrease and potassium efflux during Fas- and UV-induced cell death. J. Biol. Chem. 2001, 276:37602.
31. Wada J., Ota K., Kumar A., Wallner E.I., Kanwar Y.S. Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J. Clin. Invest. 1997, 99(10):2452-2461.
32. Wada J., Kanwar Y.S. Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin. J. Biol. Chem. 1997, 272:6078-6086.
33. Wang F., He W., Yuan J., Wu K., Zhou H., Zhang W., Chen Z.K. Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. Transpl. Immunol. 2008, 19(1):12-19.
34. Wu K., Bonavida B. The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs. Crit. Rev. Immunol. 2009, 29(3):241-254.
35. Zhu C., Anderson A.C., Schubart A., Xiong H., Imitola J., Khoury S.J., Zheng X.X., Strom T.B., Kuchroo V.K. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 2005, 6(12):1245-1252.